7 results match your criteria: "Ca' Foncello Hospital-Treviso[Affiliation]"

Article Synopsis
  • * Current treatments can have side effects and don't always work well for everyone, so there's a big need for better options.
  • * A new drug called eculizumab has been approved in Italy and might help those who don’t respond to standard treatments, and experts think it could meet the needs of many patients with MG.
View Article and Find Full Text PDF

Congenital Pouch Colon: Case Series and Review of Evidences for Resection.

J Indian Assoc Pediatr Surg

May 2021

Department of Salute della Donna e del Bambino, Division of Pediatric Surgery, University of Padova, Padova, Italy.

Background: Congenital pouch colon (CPC) is a rare variant of anorectal malformations (ARM) with its highest reported incidence in India. We aimed to describe five patients affected by CPC, in which the tissue from the terminal dilated colon has been successfully used and to discuss our results on the light of an extended revision of the literature.

Materials And Methods: The clinical details of five cases treated for CPC in two Italian Centers were retrospectively reviewed assessing the fate of the terminal dilated colon.

View Article and Find Full Text PDF

Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register.

Neurotherapeutics

April 2021

Department "G.F. Ingrassia", MS center, University of Catania, Policlinico G. Rodolico, V. Santa Sofia 78, 95123, Catania, Italy.

The current study aims to compare injectable and oral first-line disease-modifying therapies (DMTs) for time to first relapse, time to confirmed disability progression (CDP), and time to discontinuation using a cohort of relapsing remitting multiple sclerosis (RRMS) patients, with data extracted from the Italian MS Register. This multicenter, observational, retrospectively acquired, and propensity-adjusted cohort study utilized RRMS-naïve patients from the Italian MS Register who started either injectable or oral first-line DMTs between January 1, 2010, and December 31, 2017, to evaluate the impact on disability outcomes in patients. Enrolled patients were divided into two groups, namely the injectable group (IG) and the oral group (OG).

View Article and Find Full Text PDF

Purpose: Present study is designed to discover potential salivary biomarkers associated with predominantly antibody deficiencies, which include a large spectrum of disorders sharing failure of antibody production, and B cell defects resulting in recurrent infections, autoimmune and inflammatory manifestations, and tumor susceptibility. Understanding and clinical classification of these syndromes is still challenging.

Methods: We carried out a study of human saliva based on liquid chromatography-mass spectrometry measurements of intact protein mass values.

View Article and Find Full Text PDF

Monosomy of chromosome 17 may affect the assessment of HER2 amplification. Notably, the prevalence ranges from 1% up to 49% due to lack of consensus in recognition. We sought to investigate the impact of monosomy of chromosome 17 to interpretation of HER2 gene status.

View Article and Find Full Text PDF

Background: Retinopathy of prematurity (ROP) is a multifactorial disease with evidence of many associated risk factors. Erythropoietin has been reported to be associated with this disorder in a murine model, as well as in humans in some single-center reports. We reviewed the data from two large tertiary NICUs in Italy to test the hypothesis that the use of erythropoietin may be associated with the development of the most severe stages of ROP in extremely low birth weight (ELBW) neonates.

View Article and Find Full Text PDF